Hall Jesse Wayne has filed 4 insider transactions across 1 company since May 2025.
Most recent transaction: a grant/award of 98100 shares of Aclaris Therapeutics, Inc. ($ACRS) on February 02, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 2, 2026 | Aclaris Therapeutics, Inc. | $ACRS | Hall Jesse Wayne | Chief Medical Officer | A | Restricted Stock Units | 98100 | $0.00 | 98,100.0000 | 122,564,741 | 9999.99% | 0.08% |
| Feb. 2, 2026 | Aclaris Therapeutics, Inc. | $ACRS | Hall Jesse Wayne | Chief Medical Officer | A | Employee Stock Option (Right to Buy) | 343300 | $0.00 | 343,300.0000 | 122,564,741 | 9999.99% | 0.28% |
| May 1, 2025 | Aclaris Therapeutics, Inc. | $ACRS | Hall Jesse Wayne | Chief Medical Officer | A | Restricted Stock Units | 145500 | $0.00 | 145,500.0000 | 122,390,303 | 9999.99% | 0.12% |
| May 1, 2025 | Aclaris Therapeutics, Inc. | $ACRS | Hall Jesse Wayne | Chief Medical Officer | A | Employee Stock Option (right to buy) | 510000 | $0.00 | 510,000.0000 | 122,390,303 | 9999.99% | 0.42% |